TDOC Stock Recent News

Hims & Hers Health Inc (NYSE:HIMS) stock made waves in premarket trading, after the telehealth firebrand announced the pending acquisition of ZAVA, a European digital health platform.

Teladoc (TDOC) reported earnings 30 days ago. What's next for the stock?

JPMorgan analyst Lisa C. Gill maintained a Neutral rating on Teladoc Health, Inc TDOC on Thursday with a price target of $9, down from the prior $11.

Equity markets are full of bargains -- stocks that have performed terribly in recent months, whether due to trade-related marketwide issues or company-specific troubles, but could bounce back once things improve. There are also companies that are not performing well and are unlikely to rebound anytime soon; that's the kind investors should stay away from.

Teladoc Health expects Integrated Care members to be between 101 million and 103 million in 2025.

Teladoc Health needs a turnaround plan, as it lacks a growth catalyst and remains too focused on virtual mental health rather than a revolutionary telehealth technology. The virtual healthcare provider has minimal growth in chronic care enrollment where weight-loss management was supposed to drive the business. The stock is cheap, trading at 5x EV/EBITDA targets with a market cap of only $1.2 billion, but lacks sustainable growth in virtual healthcare to be a long-term investment.

PURCHASE, N.Y., May 02, 2025 (GLOBE NEWSWIRE) -- Teladoc Health, Inc. (NYSE:TDOC), the global leader in virtual care, today announced that it issued inducement awards to five new employees.

Teladoc Health, Inc. (NYSE:TDOC ) Q1 2025 Earnings Conference Call April 30, 2025 4:30 PM ET Corporate Participants Mike Minchak - Head of Investor Relations Chuck Divita - Chief Executive Officer Mala Murthy - Chief Financial Officer Conference Call Participants Jessica Tassan - Piper Sandler David Roman - Goldman Sachs Daniel Grosslight - Citi Eduardo Ron - Truist Elizabeth Anderson - Evercore Charles Rhyee - Cowen Operator Good afternoon, thank you for attending today's Teladoc Health First Quarter 2025 Earnings Call. My name is Cole and I'll be the moderator for today's call.

The headline numbers for Teladoc (TDOC) give insight into how the company performed in the quarter ended March 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

Teladoc (TDOC) came out with a quarterly loss of $0.19 per share versus the Zacks Consensus Estimate of a loss of $0.33. This compares to loss of $0.49 per share a year ago.